- Previous Close
3.0400 - Open
2.9600 - Bid 3.1000 x --
- Ask 3.1100 x --
- Day's Range
2.8700 - 3.2000 - 52 Week Range
2.8700 - 8.7300 - Volume
1,615,453 - Avg. Volume
325,059 - Market Cap (intraday)
2.294B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4100 - Earnings Date Nov 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
8.52
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.
www.curaleaf.com5,650
Full Time Employees
December 31
Fiscal Year Ends
Healthcare
Sector
Drug Manufacturers - Specialty & Generic
Industry
Recent News: CURA.TO
View More
Related Videos: CURA.TO
Performance Overview: CURA.TO
Trailing total returns as of 2024-11-07, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CURA.TO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CURA.TO
View MoreValuation Measures
Market Cap
2.26B
Enterprise Value
3.32B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.20
Price/Book (mrq)
1.64
Enterprise Value/Revenue
1.76
Enterprise Value/EBITDA
12.09
Financial Highlights
Profitability and Income Statement
Profit Margin
-14.82%
Return on Assets (ttm)
0.86%
Return on Equity (ttm)
-17.60%
Revenue (ttm)
1.36B
Net Income Avi to Common (ttm)
-194M
Diluted EPS (ttm)
-0.4100
Balance Sheet and Cash Flow
Total Cash (mrq)
89.97M
Total Debt/Equity (mrq)
78.15%
Levered Free Cash Flow (ttm)
-48.95M